The pivotal role of VEGF in tumor angiogenesis:: Molecular facts and therapeutic opportunities

被引：79
|
作者：
Siemeister, G [1 ]
Martiny-Baron, G [1 ]
Marmé, D [1 ]
机构：
[1] Univ Freiburg, Tumor Biol Ctr, Inst Mol Med, D-79106 Freiburg, Germany
来源：
CANCER AND METASTASIS REVIEWS | 1998年 / 17卷 / 02期
关键词：
D O I：
10.1023/A:1006027124696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：241 / 248
页数：8
相关论文
共 50 条
  • [41] Role of hypoxia in tumor angiogenesis—molecular and cellular angiogenic crosstalk
    Till Acker
    Karl H. Plate
    Cell and Tissue Research, 2003, 314 : 145 - 155
  • [42] The Role of Endocannabinoid System in Neuroprotection: Molecular Targets and Therapeutic Opportunities
    Thapa, Sonia
    Singh, Shashank K.
    INTEGRATIVE MEDICINE REPORTS, 2023, 2 (01): : 72 - 86
  • [43] Angiogenesis in prostate cancer: Biology and therapeutic opportunities
    Nicholson, B
    Schaefer, G
    Theodorescu, D
    CANCER AND METASTASIS REVIEWS, 2001, 20 (3-4) : 297 - 319
  • [44] Angiogenesis in Prostate Cancer: Biology and Therapeutic Opportunities
    Brian Nicholson
    Greg Schaefer
    Dan Theodorescu
    Cancer and Metastasis Reviews, 2001, 20 : 297 - 319
  • [45] The mechanopathology of the tumor microenvironment: detection techniques, molecular mechanisms and therapeutic opportunities
    Angeli, Stella
    Neophytou, Constantina
    Kalli, Maria
    Stylianopoulos, Triantafyllos
    Mpekris, Fotios
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2025, 13
  • [46] The crosstalk between senescence, tumor, and immunity: molecular mechanism and therapeutic opportunities
    Wang, Zehua
    Chen, Chen
    Ai, Jiaoyu
    Gao, Yaping
    Wang, Lei
    Xia, Shurui
    Jia, Yongxu
    Qin, Yanru
    MEDCOMM, 2025, 6 (01):
  • [47] Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors
    Malonne, H
    Langer, I
    Kiss, R
    Atassi, G
    CLINICAL & EXPERIMENTAL METASTASIS, 1999, 17 (01) : 1 - 14
  • [48] Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors
    Hugues Malonne
    Ingrid Langer
    Robert Kiss
    Ghanem Atassi
    Clinical & Experimental Metastasis, 1999, 17 : 1 - 18
  • [49] Therapeutic angiogenesis with BMDSCS engineered with conditionally silenced VEGF
    Webster, KA
    Spiga, MG
    Gounis, M
    Bishopric, NH
    Wakhloo, A
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 872 - 873
  • [50] VEGF in therapeutic coronary and peripheral artery angiogenesis.
    Elbaz, M
    Malavaud, B
    PATHOLOGIE BIOLOGIE, 1999, 47 (04): : 380 - 384
12345